Monday, August 31, 2026

Energy & Climate

2 articles

Bidgely Acquires Grid4C as Global AI Energy Market Races Toward $60.6B

US-based Bidgely acquired Israeli AI firm Grid4C in January 2025, combining grid analytics with consumer engagement into a single platform. The deal reflects mounting consolidation pressure in a market forecast to nearly triple from $22.82 billion in 2025 to $60.6 billion by 2030. Utilities worldwide are demanding fewer vendors and tighter data integration across their systems.

LM Salvado•Jun 14, 2026

Netherlands Delays Green Gas Mandate, Casting Shadow Over Europe's 2030 Biomethane Ambitions

The Netherlands has pushed back its mandatory green gas blending requirement to January 2027, raising fresh doubts about Europe's ability to scale biomethane production tenfold by 2030. The delay, cushioned by steeper initial targets, highlights a recurring tension across the energy transition: political commitment outpacing regulatory and industrial readiness. For global investors and policymakers watching Europe's green gas rollout, the Dutch stumble carries lessons well beyond its borders.

ViaNews Editorial Team•Feb 18, 2026

What we know · the intelligence behind this page

Live from the substrate

What we're seeing

Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption

Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.

Our read on the data ›

Signals we're tracking

EPKINLY Regulatory-Clinical Success Cascade

High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

Patterns we're watching ›

Where sources disagree

Morgan Stanley & Co. LLC

Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).

We flag conflicts openly ›

Recently verified

✓ Checked against the original source

4,979

facts traced to their source — and we flag the ones that don't hold up.

101 entities tracked4,979 facts checked against source5,257 source documents archived

Query this data → isubstrate.com